CRISPR hires William Blair an­a­lyst as new fi­nance chief; Tiny EU biotech rais­es $20M+

Less than 18 months af­ter hir­ing Bren­dan Smith as CFO, CRISPR Ther­a­peu­tics is bring­ing in an­oth­er ex­ec to take his place.

The Swiss-Amer­i­can gene edit­ing biotech put out word Mon­day that it is hir­ing Ra­ju Prasad as the com­pa­ny’s newest fi­nance chief, ef­fec­tive Tues­day. Prasad joins from in­vest­ment bank William Blair, where he was a se­nior re­search an­a­lyst cov­er­ing gene edit­ing and gene and cell ther­a­py.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.